Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Semaglutide Injectable bulk supplier for pharma manufacturers

Semaglutide Injectable Suppliers & Bulk Manufacturers

Available Forms: Injection(SQ)

Available Strengths: 0,25 mg - 2.4 mg per injection for weight management

Reference Brands: Wegovy(US & EU)

Category: Weight Loss drugs

Wegovy (semaglutide 2.4 mg) is a GLP-1 receptor agonist that mimics natural hormones to increase insulin secretion, suppress appetite, and slow gastric emptying. It supports weight loss, improves metabolic health, reduces hunger, and helps manage obesity, promoting long-term weight reduction and overall wellness.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Product Description:

Wegovy (semaglutide 2.4 mg) injection is approved in the US by the FDA and in the EU via EMA for chronic weight management. Regulatory approval requires comprehensive dossiers including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. The FDA reviews clinical trial and quality data for timely approval, while the EMA ensures regional safety and manufacturing compliance. For dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper adherence supports swift approval, safe administration, and global availability, helping patients worldwide achieve significant weight loss and improved metabolic health through high-quality, long-acting GLP-1 receptor agonist therapies.

Semaglutide Injectable — third party manufacturing & bulk supply

Semaglutide Injectable is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Manufacturers of Semaglutide Injectable listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Semaglutide Injectable →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Semaglutide is used to improve blood sugar control in adults with type 2 diabetes mellitus and to aid in chronic weight management for obese or overweight individuals with related health conditions. It helps lower blood glucose levels by stimulating insulin release and reducing appetite.

Semaglutide is a synthetic peptide analogue of human glucagon-like peptide-1 (GLP-1). It is produced through recombinant DNA technology in yeast and modified to resist enzymatic degradation, allowing longer activity in the body.

The main trade names of Semaglutide are Ozempic, Wegovy, and Rybelsus.

Semaglutide is manufactured by Novo Nordisk A/S.

The generic name is Semaglutide.

Brand names include Ozempic (for type 2 diabetes), Wegovy (for weight management), and Rybelsus (oral form for diabetes).

Semaglutide is manufactured by Novo Nordisk in Denmark and also at its production facilities in the United States.

Related Products

Phendimetrazine Tartrate

Strength:
35 mg, 105 mg

Form: Capsules

Reference Brands: Bontril (USA), Plegine (USA)

View Details
Phentermine Hydrochloride

Strength:
8 mg, 15 mg, 30 mg, 37.5 mg

Form: Tablets, Capsules

Reference Brands: Adipex-P (USA), Ionamin (USA)

View Details
Tesamorelin Acetate

Strength:
1mg, 2mg

Form: Injection

Reference Brands: Egrifta (USA)

View Details
Diethylpropion Hydrochloride

Strength:
25mg, 75mg

Form: Tablets

Reference Brands: Tenuate (USA)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.